Upfront treatment with Hemlibra may help minimize costs hospital associated with acquired hemophilia A, a study found.

MacDonald remembers the challenges her youngest son faced, but is amazed at how he navigates life with hemophilia.

Columnist Joe MacDonald urges others to show compassion, even if they don't understand why someone needs to use a mobility aid.

Columnist Allyx Formalejo tackles the subject of living independently with bleeding disorders and lands on a single concept: ...

Pediatric hematologist Shannon Walker, MD, answers key clinical questions surrounding treatment goals and selection, inhibitor screening, breakthrough bleeds, and more. These short, focused Q&As ...

Switching clotting factor products did not cause new inhibitors (neutralizing antibodies that can prevent the treatment from working) to develop in previously treated patients with moderate or severe ...

Her son manages his care with the words, "I've got this," and columnist Cazandra Campos-MacDonald learns her hands-on days are behind her.

What is Rebinyn for hemophilia? Rebinyn (nonacog beta pegol) is an extended half-life factor IX product approved to prevent and control bleeding in people with hemophilia B, including bleeding during ...

The main symptom of hemophilia is unusual bleeding. This can be bleeding that lasts longer than normal after an injury or medical procedure, but in more severe cases, it can happen without any obvious ...

Hemophilia, a disorder characterized by excessive bleeding, is caused by the lack of activity of certain clotting factors, which are proteins that are needed to form blood clots. Most cases of ...

Hemophilia is a blood disorder that is characterized by a shortage of specific clotting factors that help to form blood clots and stop bleeding. Historically, the primary treatment for hemophilia is ...

New analysis highlights delayed hemophilia diagnosis, treatment inequities and research gaps affecting women and girls.